Integrating Exposure and Response Prevention and Habit Reversal Techniques to Treat a Tourettic Subtype of Obsessive-Compulsive Disorder (Tourettic OCD) | MicrobiomeTrials
Integrating Exposure and Response Prevention and Habit Reversal Techniques to Treat a Tourettic Subtype of Obsessive-Compulsive Disorder (Tourettic OCD)
RecruitingNAINTERVENTIONAL
Trial Details
Start: 2026-07-08Est. Completion: 2027-08-01
Enrollment target: 40 participants
Locations
University College London Hospitals NHS Foundation Trust, London, London, United Kingdom
University College London Queen Square Institute of Neurology, London, London, United Kingdom